Teladoc officer plans sale of 5,439 shares

Teladoc Health, Inc. (TDOC) received a Rule 144 notice that officer Fernando Madeira Rodrigues intends to sell 5,439 shares of common stock through Fidelity Brokerage Services LLC on the NYSE.

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) received a Rule 144 notice that officer Fernando Madeira Rodrigues intends to sell 5,439 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. The shares relate to restricted stock vesting on September 1, 2026, with part of the sale covering tax obligations from the equity award settlement.

The notice also lists prior sales by Rodrigues over the past three months totaling 15,249 shares of common stock for an aggregate of $114,131.29.

Key Figures

Shares to be sold (current notice): 5,439 shares Aggregate market value (current notice): $34,272.77 Shares sold June 2, 2026: 5,677 shares +5 more

8 metrics

Shares to be sold (current notice) 5,439 shares Common stock covered by the September 2, 2026 Rule 144 notice

Aggregate market value (current notice) $34,272.77 Estimated market value of 5,439 shares listed with broker

Shares sold June 2, 2026 5,677 shares Common stock sold by Fernando Madeira Rodrigues on June 2, 2026

Proceeds June 2, 2026 sale $43,298.49 Value of Teladoc Health common stock sold on June 2, 2026

Shares sold June 3, 2026 9,572 shares Common stock sold by Fernando Madeira Rodrigues on June 3, 2026

Proceeds June 3, 2026 sale $70,832.80 Value of Teladoc Health common stock sold on June 3, 2026

Total shares sold in past three months 15,249 shares Sum of June 2 and June 3, 2026 transactions reported

Total proceeds in past three months $114,131.29 Combined value of June 2 and June 3, 2026 sales

Key Terms

Rule 144, restricted stock vesting, vested equity award distribution, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 09/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

vested equity award distribution financial

"resulting from the settlement of a vested equity award distribution."

attorney-in-fact regulatory

"as attorney-in-fact for Fernando Madeira Rodrigues"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Teladoc Health (TDOC)?

The filing discloses that officer Fernando Madeira Rodrigues intends to sell 5,439 shares of Teladoc Health common stock under Rule 144, related to a restricted stock vesting that occurred on September 1, 2026.

How many Teladoc Health (TDOC) shares is the insider planning to sell now?

The notice reports a planned sale of 5,439 shares of Teladoc Health common stock. The sale is associated with the settlement of a vested equity award and includes an amount intended to cover a related tax obligation.

What were Fernando Madeira Rodrigues’ recent sales of TDOC shares?

Over the past three months, Rodrigues sold 5,677 shares on June 2, 2026 for $43,298.49 and 9,572 shares on June 3, 2026 for $70,832.80, all Teladoc Health common stock.

What is the reported market value of the Teladoc Health shares to be sold?

The Form 144 lists an aggregate market value of $34,272.77 for the 5,439 shares of Teladoc Health common stock covered by the current notice, as recorded with Fidelity Brokerage Services LLC.

Why does the Teladoc Health (TDOC) Form 144 mention taxes?

A remark states the sale includes an amount necessary to cover a tax obligation arising from the settlement of a vested equity award distribution, indicating part of the planned sale proceeds is tied to tax payments on that compensation.

Which broker is handling the planned TDOC share sale under Form 144?

The filing identifies Fidelity Brokerage Services LLC as the broker for the 5,439-share Teladoc Health sale. The notice is signed by Adam Gehring as a duly authorized representative and attorney-in-fact for Fernando Madeira Rodrigues.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:01 PM EDT Accepted by SEC EDGAR 09/02/2026 - 04:01 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002037547
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	Rodrigues Fernando M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5439	34272.77	181684021	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock Vesting	Issuer			5439	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Fernando Madeira Rodrigues 155 E 44th Street Suite 1700 New York NY 10017	Common	06/02/2026	5677	43298.49
Fernando Madeira Rodrigues 155 E 44th Street Suite 1700 New York NY 10017	Common	06/03/2026	9572	70832.80

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Fernando Madeira Rodrigues
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)